WASHINGTON--(BUSINESS WIRE)--Today, the House Science and Technology Committee’s Technology and Innovation Subcommittee will explore how the Small Business Research Innovation (SBIR) programs operate at the largest government agencies. The Biotechnology Industry Organization (BIO) has called for reform of the SBIR eligibility requirement which prevents more than half of all small private U.S. biotech companies from competing for grants to fund research that could lead to potentially life-enhancing and life-saving therapies.
